Unilever to invest €40 million in India R&D and bio‑futures innovation
Summary
- Unilever will allocate €40 million (approximately ₹3.6 billion) to strengthen its research and development centre in India.
- The funding will focus on bio‑futures innovation, including sustainable ingredients, biotechnology and green chemistry.
- India is positioned by Unilever as a critical global hub for its innovation pipeline, reflecting the country's growing R&D capabilities.
- The investment is expected to create new high‑skill jobs and foster collaborations with Indian research institutes and start‑ups.
Key Facts
- · Investment amount: €40 million (≈₹3.6 billion).
- · Target area: bio‑futures and sustainable product innovation.
- · Unilever's global R&D network includes 14 centres; India is now a priority hub.
- · The initiative aligns with India's 'Make in India' and biotechnology promotion policies.
- · Projected creation of 200–300 research and technical positions over the next 3 years.
Why it matters
The infusion of private‑sector R&D capital underscores India's emergence as a global innovation hub, boosting the biotech ecosystem, creating high‑skill employment and supporting national objectives of sustainable manufacturing and self‑reliance.
#Unilever#R&D#Bio-futures#Innovation#India#Investment